Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients

Authors
Category Primary study
JournalGut
Year 2018
This article has no abstract
Epistemonikos ID: 3b55588ef79abb9e970adef3567a6753d9f783c0
First added on: Feb 09, 2025